Pharmaceutical Development Associates Charlotte, NC - 28262

Pharmaceutical Development Associates is categorized under Business Services (Unclassified) in Charlotte, NC .

Pharmaceutical Development Associates was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.

If you are seeking more information, feel free to contact at the company’s single location by writing to 8701 Mallard Creek Road, Charlotte, North Carolina NC 28262 or by phoning (256) 831-0410. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Pharmaceutical Development Associates
Address: 8701 Mallard Creek Road, Charlotte, North Carolina 28262
Phone Number: (256) 831-0410
Annual Revenue (USD): $100.000 to $499.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Business Services (Unclassified)
SIC Code: 7389
NAICS Code: 561499
Share This Business:

Pharmaceutical Development Associates was started in 0 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact for inquiries that concern Pharmaceutical Development Associates by calling the company number (256) 831-0410, as your correspondence is most welcome. Additionally, the physical location of the single location of Pharmaceutical Development Associates can be found at the coordinates as well as the street address 8701 Mallard Creek Road in Charlotte, North Carolina 28262.

For its online presence, you may visit Pharmaceutical Development Associates’s website at and engage with its social media outlets through on Twitter and on Facebook.